Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct-acting antiviral experienced hepatitis C patients.

Belperio PS, Shahoumian TA, Loomis TP, Backus LI.

J Viral Hepat. 2019 Aug;26(8):980-990. doi: 10.1111/jvh.13115. Epub 2019 May 10.

PMID:
31012179
2.

West Nile Virus in Hummingbirds in California, USA, 2005-2017.

Backus L, Foss L, Tell L.

J Wildl Dis. 2019 Apr 5. [Epub ahead of print]

PMID:
30951397
3.

Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3.

Belperio PS, Shahoumian TA, Loomis TP, Mole LA, Backus LI.

J Hepatol. 2019 Jan;70(1):15-23. doi: 10.1016/j.jhep.2018.09.018. Epub 2018 Sep 26.

PMID:
30266283
4.

Impact of IFNL4-∆G genotype on sustained virologic response in hepatitis C genotype 1 patients treated with direct-acting antivirals.

Backus LI, Shahoumian TA, Belperio PS, Winters M, Prokunina-Olsson L, O'Brien TR, Holodniy M.

Diagn Microbiol Infect Dis. 2018 Sep;92(1):34-36. doi: 10.1016/j.diagmicrobio.2018.04.004. Epub 2018 Apr 14.

PMID:
29866411
5.

Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.

Belperio PS, Chartier M, Gonzalez RI, Park AM, Ross DB, Morgan TR, Backus LI.

Infect Dis Clin North Am. 2018 Jun;32(2):281-292. doi: 10.1016/j.idc.2018.02.011. Review.

PMID:
29778256
6.

Monitoring VHA Optometric Eye Exam Services, Nation-Wide, 2014-2016.

Fant G, Backus L.

Mil Med. 2018 Mar 13. doi: 10.1093/milmed/usx192. [Epub ahead of print]

PMID:
29546420
7.

Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease.

Backus LI, Belperio PS, Shahoumian TA, Mole LA.

Hepatology. 2018 Sep;68(3):827-838. doi: 10.1002/hep.29811. Epub 2018 May 14.

PMID:
29377196
8.

Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.

Mücke MM, Backus LI, Mücke VT, Coppola N, Preda CM, Yeh ML, Tang LSY, Belperio PS, Wilson EM, Yu ML, Zeuzem S, Herrmann E, Vermehren J.

Lancet Gastroenterol Hepatol. 2018 Mar;3(3):172-180. doi: 10.1016/S2468-1253(18)30002-5. Epub 2018 Jan 19. Review.

PMID:
29371017
9.

Understanding Treatment Burden and Quality of Life Impact of Participating in an Early-Phase Pediatric Oncology Clinical Trial: A Pilot Study.

Crane S, Backus L, Stockman B, Carpenter JS, Lin L, Haase J.

J Pediatr Oncol Nurs. 2018 Jan/Feb;35(1):25-35. doi: 10.1177/1043454217723863. Epub 2017 Aug 29.

10.

Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease.

Backus LI, Belperio PS, Shahoumian TA, Mole LA.

Hepatology. 2019 Feb;69(2):487-497. doi: 10.1002/hep.29408. Epub 2018 May 15.

PMID:
28749564
11.

Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients.

Streby KA, Geller JI, Currier MA, Warren PS, Racadio JM, Towbin AJ, Vaughan MR, Triplet M, Ott-Napier K, Dishman DJ, Backus LR, Stockman B, Brunner M, Simpson K, Spavin R, Conner J, Cripe TP.

Clin Cancer Res. 2017 Jul 15;23(14):3566-3574. doi: 10.1158/1078-0432.CCR-16-2900. Epub 2017 May 11.

12.

Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States Veterans.

Noska AJ, Belperio PS, Loomis TP, O'Toole TP, Backus LI.

Clin Infect Dis. 2017 Jul 15;65(2):252-258. doi: 10.1093/cid/cix295.

13.

Draft Genome Sequences of 24 Lactococcus lactis Strains.

Backus L, Wels M, Boekhorst J, Dijkstra AR, Beerthuyzen M, Kelly WJ, Siezen RJ, van Hijum SA, Bachmann H.

Genome Announc. 2017 Mar 30;5(13). pii: e01737-16. doi: 10.1128/genomeA.01737-16.

14.

Draft Genome Sequences of 11 Lactococcus lactis subsp. cremoris Strains.

Wels M, Backus L, Boekhorst J, Dijkstra A, Beerthuyzen M, Siezen RJ, Bachmann H, van Hijum SA.

Genome Announc. 2017 Mar 16;5(11). pii: e01739-16. doi: 10.1128/genomeA.01739-16.

15.

Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.

Belperio PS, Shahoumian TA, Mole LA, Backus LI.

Hepatology. 2017 Jul;66(1):27-36. doi: 10.1002/hep.29135. Epub 2017 May 18.

PMID:
28240789
16.

Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice.

Bhattacharya D, Belperio PS, Shahoumian TA, Loomis TP, Goetz MB, Mole LA, Backus LI.

Clin Infect Dis. 2017 Jun 15;64(12):1711-1720. doi: 10.1093/cid/cix111.

17.

Engagement in the Hepatitis C Care Cascade Among Homeless Veterans, 2015.

Noska AJ, Belperio PS, Loomis TP, O'Toole TP, Backus LI.

Public Health Rep. 2017 Mar/Apr;132(2):136-139. doi: 10.1177/0033354916689610. Epub 2017 Jan 30.

18.

Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients.

Backus LI, Belperio PS, Shahoumian TA, Loomis TP, Mole LA.

Antivir Ther. 2017;22(6):481-493. doi: 10.3851/IMP3117. Epub 2016 Dec 9.

PMID:
27934775
19.

Hepatitis C testing in U.S. veterans born 1945-1965: An update.

Ross DB, Belperio PS, Chartier M, Backus LI.

J Hepatol. 2017 Jan;66(1):237-238. doi: 10.1016/j.jhep.2016.09.018. Epub 2016 Oct 5. No abstract available.

PMID:
27720804
20.

Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.

Backus LI, Belperio PS, Shahoumian TA, Loomis TP, Mole LA.

Aliment Pharmacol Ther. 2016 Aug;44(4):400-10. doi: 10.1111/apt.13696. Epub 2016 Jun 13.

21.

Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients.

Backus LI, Belperio PS, Shahoumian TA, Loomis TP, Mole LA.

Hepatology. 2016 Aug;64(2):405-14. doi: 10.1002/hep.28625. Epub 2016 Jun 7.

PMID:
27115523
22.

Cigarette Smoking, Reduction and Quit Attempts: Prevalence Among Veterans With Coronary Heart Disease.

Shahoumian TA, Phillips BR, Backus LI.

Prev Chronic Dis. 2016 Mar 24;13:E41. doi: 10.5888/pcd13.150282.

23.

Draft Genome Sequence of Lactobacillus plantarum SF2A35B.

Bron PA, Lee IC, Backus L, van Hijum SA, Wels M, Kleerebezem M.

Genome Announc. 2016 Feb 25;4(1). pii: e01638-15. doi: 10.1128/genomeA.01638-15.

24.

A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.

Hummel TR, Salloum R, Drissi R, Kumar S, Sobo M, Goldman S, Pai A, Leach J, Lane A, Pruitt D, Sutton M, Chow LM, Grimme L, Doughman R, Backus L, Miles L, Stevenson C, Fouladi M, DeWire M.

J Neurooncol. 2016 Mar;127(1):53-61. doi: 10.1007/s11060-015-2008-6. Epub 2015 Dec 1.

PMID:
26626490
25.

Draft Genome Sequence of Streptococcus thermophilus C106, a Dairy Isolate from an Artisanal Cheese Produced in the Countryside of Ireland.

Wels M, Serrano LM, Eibrink BJ, Backus L, Bongers RS, Vriesendorp B, Siezen RJ, van Hijum SA, Meijer WC.

Genome Announc. 2015 Nov 25;3(6). pii: e01377-15. doi: 10.1128/genomeA.01377-15.

26.

Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.

Maier MM, Ross DB, Chartier M, Belperio PS, Backus LI.

Am J Public Health. 2016 Feb;106(2):353-8. doi: 10.2105/AJPH.2015.302927. Epub 2015 Nov 12.

27.

Surveyed Enrollees in Veterans Affairs Health Care: How They Differ From Eligible Veterans Surveyed by BRFSS.

Phillips BR, Shahoumian TA, Backus LI.

Mil Med. 2015 Nov;180(11):1161-9. doi: 10.7205/MILMED-D-14-00462.

PMID:
26540708
28.

Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans.

Backus LI, Belperio PS, Shahoumian TA, Loomis TP, Mole LA.

Aliment Pharmacol Ther. 2015 Sep;42(5):559-73. doi: 10.1111/apt.13300. Epub 2015 Jun 26.

29.

HIV Care Continuum Applied to the US Department of Veterans Affairs: HIV Virologic Outcomes in an Integrated Health Care System.

Backus L, Czarnogorski M, Yip G, Thomas BP, Torres M, Bell T, Ross D.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):474-80. doi: 10.1097/QAI.0000000000000615.

PMID:
25835603
30.

The State of Hepatitis C Care in the VA.

Belperio PS, Fox RK, Backus LI.

Fed Pract. 2015 Feb;32(Suppl 2):20S-24S.

31.

Screening for and prevalence of hepatitis B virus infection among high-risk veterans under the care of the U.S. Department of Veterans Affairs: a case report.

Backus LI, Belperio PS, Loomis TP, Han SH, Mole LA.

Ann Intern Med. 2014 Dec 16;161(12):926-8. doi: 10.7326/L14-5036. No abstract available.

PMID:
25506867
32.

Effectiveness research in the evolving HCV landscape.

Backus LI, Belperio PS.

Dig Dis Sci. 2014 Dec;59(12):2845-7. doi: 10.1007/s10620-014-3345-6. No abstract available.

PMID:
25190262
33.

Impact of race/ethnicity and gender on HCV screening and prevalence among U.S. veterans in Department of Veterans Affairs Care.

Backus LI, Belperio PS, Loomis TP, Mole LA.

Am J Public Health. 2014 Sep;104 Suppl 4:S555-61. doi: 10.2105/AJPH.2014.302090.

34.

A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.

Belperio PS, Backus LI, Ross D, Neuhauser MM, Mole LA.

J Manag Care Spec Pharm. 2014 Jun;20(6):533-40.

35.

Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans.

Goldberg DS, French B, Forde KA, Groeneveld PW, Bittermann T, Backus L, Halpern SD, Kaplan DE.

JAMA. 2014 Mar 26;311(12):1234-43. doi: 10.1001/jama.2014.2520.

36.

Impact of provider type on hepatitis C outcomes with boceprevir-based and telaprevir-based regimens.

Backus LI, Belperio PS, Shahoumian TA, Mole LA.

J Clin Gastroenterol. 2015 Apr;49(4):329-35. doi: 10.1097/MCG.0000000000000124.

PMID:
24667591
37.

Impact of rural residence and health system structure on quality of liver care.

Rongey C, Shen H, Hamilton N, Backus LI, Asch SM, Knight S.

PLoS One. 2013 Dec 26;8(12):e84826. doi: 10.1371/journal.pone.0084826. eCollection 2013.

38.

Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort.

Backus LI, Belperio PS, Shahoumian TA, Cheung R, Mole LA.

Aliment Pharmacol Ther. 2014 Jan;39(1):93-103. doi: 10.1111/apt.12546. Epub 2013 Nov 10.

39.

Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care.

Backus LI, Belperio PS, Loomis TP, Yip GH, Mole LA.

JAMA Intern Med. 2013 Sep 9;173(16):1549-52. doi: 10.1001/jamainternmed.2013.8133. No abstract available.

PMID:
23835865
40.

Screening metatranscriptomes for toxin genes as functional drivers of human colorectal cancer.

Dutilh BE, Backus L, van Hijum SA, Tjalsma H.

Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):85-99. doi: 10.1016/j.bpg.2013.03.008. Review.

PMID:
23768555
41.

Impact of sustained virologic response on all-cause mortality.

Backus LI, Belperio PS.

Hepatology. 2013 Oct;58(4):1508-10. doi: 10.1002/hep.26504. Epub 2013 Aug 6. No abstract available.

PMID:
23703903
42.

Explaining microbial phenotypes on a genomic scale: GWAS for microbes.

Dutilh BE, Backus L, Edwards RA, Wels M, Bayjanov JR, van Hijum SA.

Brief Funct Genomics. 2013 Jul;12(4):366-80. doi: 10.1093/bfgp/elt008. Epub 2013 Apr 26. Review.

43.

Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.

Belperio PS, Hwang EW, Thomas IC, Mole LA, Cheung RC, Backus LI.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):1021-7. doi: 10.1016/j.cgh.2013.03.006. Epub 2013 Mar 21.

PMID:
23524130
44.

Unintended consequences: abortion training in the years after Roe v Wade.

Aksel S, Fein L, Ketterer E, Young E, Backus L.

Am J Public Health. 2013 Mar;103(3):404-7. doi: 10.2105/AJPH.2012.301152. Epub 2013 Jan 17.

45.

Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.

Hwang EW, Thomas IC, Cheung R, Backus LI.

J Clin Gastroenterol. 2013 Mar;47(3):264-70. doi: 10.1097/MCG.0b013e31827035cf.

PMID:
23269309
46.

Data mining in the Life Sciences with Random Forest: a walk in the park or lost in the jungle?

Touw WG, Bayjanov JR, Overmars L, Backus L, Boekhorst J, Wels M, van Hijum SA.

Brief Bioinform. 2013 May;14(3):315-26. doi: 10.1093/bib/bbs034. Epub 2012 Jul 10.

47.

Implications of rapid virological response in hepatitis C therapy in the US veteran population.

Hwang EW, Thomas IC, Cheung R, Backus LI.

Aliment Pharmacol Ther. 2012 Jan;35(1):105-15. doi: 10.1111/j.1365-2036.2011.04903.x. Epub 2011 Nov 7.

48.

Medical students for choice: creating tomorrow's abortion providers.

Evans ML, Backus LV.

Contraception. 2011 May;83(5):391-3. doi: 10.1016/j.contraception.2011.01.019. Epub 2011 Mar 9. No abstract available.

PMID:
21477678
49.

Assessment of the quality of diabetes care for HIV-infected patients in a national health care system.

Backus LI, Boothroyd D, Philips B, Belperio P, Halloran J, Mole L.

AIDS Patient Care STDS. 2011 Apr;25(4):203-6. doi: 10.1089/apc.2010.0379. Epub 2011 Mar 15. No abstract available.

PMID:
21406005
50.

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

Backus LI, Boothroyd DB, Phillips BR, Belperio P, Halloran J, Mole LA.

Clin Gastroenterol Hepatol. 2011 Jun;9(6):509-516.e1. doi: 10.1016/j.cgh.2011.03.004. Epub 2011 Mar 11.

PMID:
21397729

Supplemental Content

Loading ...
Support Center